CHANGES OF INTERLEUKINS IN PATIENTS WITH NOSOCOMIAL PNEUMONIA AGAINST A BACKGROUND OF TRAUMATIC BRAIN INJURY: ROLE IN THE DIAGNOSIS AND MONITORING OF DISEASE

Anastasiia Ilchenko

Abstract


Introduction. Nosocomial pneumonia (NP) is the second leading frequency and mortality among nosocomial infections. NP is a frequent complication of severe traumatic brain injury (TBI). The difficulty in diagnosis and monitoring of disease NP on the background of TBI is that the usual signs NP "masked" manifestations of the underlying disease.

The aim of our study was to improve the diagnosis and assess the effectiveness of the treatment of nosocomial pneumonia with clarithromycin by studying of serum interleukins in patients with nosocomial pneumonia on the background of traumatic brain injury.

Materials and methods. We determined levels of TNFα, IL-4, IL-6, IL-8, IL-10.  We examined 45 patients with isolated TBI, 44 patients with NP (standard treatment scheme), 49  patients with NP, each therapy with clarithromycin. The control group was 33 relatively healthy people.

Conclusions. The study revealed a significant increase in the concentration of interleukin TNFα, IL-6, IL-8, IL-10 in the serum of patients with NP on the background of TBI compared with patients with isolated TBI and healthy individuals. Our study found significantly lower concentrations of interleukin TNFα, IL-6, IL-8, IL-10 in the serum of patients after treatment with the addition of clarithromycin compared with patients with standard therapy.

Keywords


nosocomial pneumonia; traumatic brain injury; diagnosis; cytokines; clarithromycin

Full Text:

PDF

References


Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia (2005). American Journal of Respiratory and Critical Care Medicine, 171 (4), 388–416. doi: 10.1164/rccm.200405-644st

Barbier, F., Andremont, A., Wolff, M., Bouadma, L. (2013). Hospital-acquired pneumonia and ventilator-associated pneumonia. Current Opinion in Pulmonary Medicine, 19 (3), 216–228. doi: 10.1097/mcp.0b013e32835f27be

Chuchalin, A. G. (2015). Pneumonia as an actual medical problem of the 21th century. Pulmonology, 25 (2), 133–142. doi: 10.18093/0869-0189-2015-25-2-133-142

Feshchenko, Yu. I., Dziublyk, Yu. I., Simonov, S. S. (2012). Hospitalna (nozokomialna) pnevmoniia u doroslykh osib: etiolohiia, patohenez, klasyfikatsiia, diahnostyka, antybakterialna terapiia [Hospital (nosocomial) pneumonia in adults: etiology, pathogenesis, classification, diagnosis, antibiotic therapy]. Zdorovia Ukrainy, 1 (278), 35–36.

Giamarellos-Bourboulis, E. J., Mylona, V., Antonopoulou, A., Tsangaris, I., Koutelidakis, I., Marioli, A. et. al. (2013). Effect of clarithromycin in patients with suspected Gram-negative sepsis: results of a randomized controlled trial. Journal of Antimicrobial Chemotherapy, 69 (4), 1111–1118. doi: 10.1093/jac/dkt475

Gogos, C. A., Drosou, E., Bassaris, H. P., Skoutelis, A. (2000). Pro‐versus Anti‐inflammatory Cytokine Profile in Patients with Severe Sepsis: A Marker for Prognosis and Future Therapeutic Options. The Journal of Infectious Diseases, 181 (1), 176–180. doi: 10.1086/315214

Patella, M., Anile, M., Del Porto, P., Diso, D., Pecoraro, Y., Onorati, I. et. al. (2014). Role of cytokine profile in the differential diagnosis between acute lung rejection and pulmonary infections after lung transplantation. European Journal of Cardio-Thoracic Surgery, 47 (6), 1031–1036. doi: 10.1093/ejcts/ezu395

Abouelela, A., Al-Badawy, T., Abdel Gawad, M. (2015). Predictive value of different scoring systems for critically ill patients with hospital acquired pneumonia. Intensive Care Medicine Experimental, 3 (1), A345–A347. doi: 10.1186/2197-425x-3-s1-a345

Rotstein, C., Evans, G., Born, A., Grossman, R., Light, R. B., Magder, S. et. al. (2008). Clinical Practice Guidelines for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia in Adults. Canadian Journal of Infectious Diseases and Medical Microbiology, 19 (1), 19–53. doi: 10.1155/2008/593289

Rice, T. W., Wheeler, A. P., Morris, P. E., Paz, H. L., Russell, J. A., Edens, T. R., Bernard, G. R. (2006). Safety and efficacy of affinity-purified, anti–tumor necrosis factor-α, ovine fab for injection (CytoFab) in severe sepsis. Critical Care Medicine, 34 (9), 2271–2281. doi: 10.1097/01.ccm.0000230385.82679.34

Spyridaki, A., Raftogiannis, M., Antonopoulou, A., Tsaganos, T., Routsi, C., Baziaka, F. et. al. (2012). Effect of Clarithromycin in Inflammatory Markers of Patients with Ventilator-Associated Pneumonia and Sepsis Caused by Gram-Negative Bacteria: Results from a Randomized Clinical Study. Antimicrobial Agents and Chemotherapy, 56 (7), 3819–3825. doi: 10.1128/aac.05798-11

Taylor, G., Gravel, D., Matlow, A., Embree, J., LeSaux, N. et. al. (2016). Assessing the magnitude and trends in hospital acquired infections in Canadian hospitals through sequential point prevalence surveys. Antimicrobial Resistance & Infection Control, 5 (1), 19–25. doi: 10.1186/s13756-016-0118-3

Tsaganos, T., Raftogiannis, M., Pratikaki, M., Christodoulou, S., Kotanidou, A., Papadomichelakis, E. et. al. (2016). Clarithromycin Leads to Long-Term Survival and Cost Benefit in Ventilator-Associated Pneumonia and Sepsis. Antimicrobial Agents and Chemotherapy, 60 (6), 3640–3646. doi: 10.1128/aac.02974-15

Gikas, A., Roumbelaki, M., Bagatzouni-Pieridou, D., Alexandrou, M., Zinieri, V., Dimitriadis, I., Kritsotakis, E. I. (2010). Device-associated infections in the intensive care units of Cyprus: results of the first national incidence study. Infection, 38 (3), 165–171. doi: 10.1007/s15010-010-0007-2

Xia, J., Gao, J., Tang, W. (2016). Nosocomial infection and its molecular mechanisms of antibiotic resistance. BioScience Trends, 10 (1), 14–21. doi: 10.5582/bst.2016.01020

Kollef, M. H., Hamilton, C. W., Ernst, F. R. (2012). Economic Impact of Ventilator-Associated Pneumonia in a Large Matched Cohort. Infection Control & Hospital Epidemiology, 33 (03), 250–256. doi: 10.1086/664049

Van Vught, L. A., Scicluna, B. P., Wiewel, M. A., Hoogendijk, A. J., Klein Klouwenberg, P. M. C., Franitza, M. et. al. (2016). Comparative Analysis of the Host Response to Community-acquired and Hospital-acquired Pneumonia in Critically Ill Patients. American Journal of Respiratory and Critical Care Medicine, 194 (11), 128–133. doi: 10.1164/rccm.201602-0368oc

Micek, S. T., Chew, B., Hampton, N., Kollef, M. H. (2016). A Case-Control Study Assessing the Impact of Nonventilated Hospital-Acquired Pneumonia on Patient Outcomes. Chest, 150 (5), 1008–1014. doi: 10.1016/j.chest.2016.04.009

Mouktaroudi, M., Giamarellos-Bourboulis, E. J. (2012). Macrolides for the therapy of nosocomial infections. Current Opinion in Infectious Diseases, 25 (2), 205–210. doi: 10.1097/qco.0b013e32834ff1b4

Radzikowska, E., Roży, A., Jaguś, P., Wiatr, E., Gawryluk, D., Chorostowska-Wynimko, J., Roszkowski-Śliż, K. (2016). Cryptogenic Organizing Pneumonia: IL-1β, IL-6, IL-8, and TGF- β1 Serum Concentrations and Response to Clarithromycin Treatment. Advances in Respiratory Cancerogenesis, 911, 77–85. doi: 10.1007/5584_2016_223

Zilberberg, M. D., Shorr, A. F. (2010). Ventilator‐Associated Pneumonia: The Clinical Pulmonary Infection Score as a Surrogate for Diagnostics and Outcome. Clinical Infectious Diseases, 51 (S1), S131–S135. doi: 10.1086/653062

Zeng, M., Li, Z.-Y., Ma, J., Cao, P.-P., Wang, H., Cui, Y.-H., Liu, Z. (2015). Clarithromycin and dexamethasone show similar anti-inflammatory effects on distinct phenotypic chronic rhinosinusitis: an explant model study. BMC Immunology, 16 (1), 16–37. doi: 10.1186/s12865-015-0096-x

Eachempati, S. R., Hydo, L. J., Shou, J., Barie, P. S. (2010). The Pathogen of Ventilator-Associated Pneumonia Does Not Influence the Mortality Rate of Surgical Intensive Care Unit Patients Treated with a Rotational Antibiotic System. Surgical Infections, 11 (1), 13–20. doi: 10.1089/sur.2008.025




DOI: http://dx.doi.org/10.21303/2504-5679.2017.00279

Refbacks

  • There are currently no refbacks.




Copyright (c) 2017 Anastasiia Ilchenko

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN 2504-5679 (Online), ISSN 2504-5660 (Print)